[ad_1]
The Chinese medical insurance administration will begin a new round of negotiations with pharmaceutical companies to add more anti-cancer drugs to the insurance list, the administration said Friday.
Representatives of 10 foreign and 8 national companies expressed their willingness to work with the authority to ensure that patients have access to cancer drugs and can afford them.
In order to reduce prices and improve the supply of cancer drugs, China has included the majority of the most used and clinically effective cancer drugs. By negotiating with drug companies to lower prices and add more drugs to the insurance system, the financial burden for patients has been significantly reduced, according to the administration.
Since May 1, import tariffs exempted from all common drugs, including cancer drugs, cancer-alkaloid-based drugs and imported traditional Chinese medicine. 19659005]
[ad_2]
Source link
